Want to join the conversation?
In February 2015, $REGN and Sanofi entered into an amended ZALTRAP agreement under which Sanofi is solely responsible for the development and commercialization of ZALTRAP Injection for Intravenous Infusion for cancer indications worldwide. Sanofi bears the cost of all development & commercialization activities and reimburses $REGN for its costs.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?